EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk assessment for cardiovascular adverse drug events in the ICU: Case study on COVID-19 patients

Natalia L Freitas, Raiane Diniz Oliveira, Ana Katarina da Silva Santos, Marcilio Cunha-Filho iD, Patricia Medeiros-Souza

PLOS One · 24.03.2026 · 21 (3) · e0345280

DOI: 10.1371/journal.pone.0345280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 24.03.2026. Verfasst von Natalia L Freitas und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, University of Brasilia (UnB), Brasília, DF, Brazil. Hauptthemen laut MEDLINE: Intensive Care Units, COVID-19, Cardiovascular Diseases, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Apoio à Pesquisa do Distrito Federal, Universidade de Brasília.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 outbreak quickly became a pandemic. In Brazil, more than seven million cases were recorded in 2020. Most patients affected by the disease were admitted to intensive care units (ICU), requiring qualitative polypharmacy, increasing the risk of serious adverse drug reactions (ADE), especially cardiovascular. This study aimed to identify cardiovascular ADE in the ICU of a reference hospital for the treatment of COVID-19 in Brasília, Brazil. The Tisdale score was determined by analyzing 141 medical records of patients with COVID-19 admitted in 2020. Furthermore, the MedUTI software was used to simulate hypothetical drug substitutions to reduce cardiovascular risk. The result showed that after simulating the hypothetical intervention of prescriptions, a 53% decrease in high-risk patients was observed (from 96.0% to 43.0%). In this optimized prescription condition, 56% of them began to show a Tisdale score of medium or low risk. In addition, a decrease from 67 to 51 of medications with serious cardiovascular ADE was noted, i.e., QT interval prolongation (from 37 to 30), Torsades de Pointes (from 21 to 15), and SS (from 9 to 6). The COVID-19 medical emergency has highlighted the need for rapid medication management in ICU patients. Thus, the use of technologies to support healthcare professionals’ work can be decisive for patient survival, especially in ICU overcrowding scenarios.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intensive Care UnitsCOVID-19Cardiovascular DiseasesDrug-Related Side Effects and Adverse ReactionsHumansRisk AssessmentBrazilFemaleMaleMiddle AgedAgedSARS-CoV-2PandemicsAdult

Autor:innen und Institutionen

  • School of Health Sciences, University of Brasilia (UnB), Brasília, DF, Brazil.
  • Department of Health of Distrito Federal (SES-DF), Brasília, DF, Brazil.
  • Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, Brasília, DF, Brazil.

ORCID-Profile: Marcilio Cunha-Filho

Förderung

  • Fundação de Apoio à Pesquisa do Distrito Federal
  • Universidade de Brasília

Zitieren

APA

Freitas, N. L., Oliveira, R. D., Santos, A. K. D. S., Cunha-Filho, M., & Medeiros-Souza, P. (2026). Risk assessment for cardiovascular adverse drug events in the ICU: Case study on COVID-19 patients. PLOS One, 21(3), e0345280. https://doi.org/10.1371/journal.pone.0345280

Vancouver

Freitas NL, Oliveira RD, Santos AKDS, Cunha-Filho M, Medeiros-Souza P. Risk assessment for cardiovascular adverse drug events in the ICU: Case study on COVID-19 patients. PLOS One. 2026;21(3):e0345280. doi:10.1371/journal.pone.0345280

BibTeX
@article{Freitas2026,
  author = {Freitas, Natalia L and Oliveira, Raiane Diniz and Santos, Ana Katarina da Silva and Cunha-Filho, Marcilio and Medeiros-Souza, Patricia},
  title = {Risk assessment for cardiovascular adverse drug events in the ICU: Case study on COVID-19 patients},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0345280},
  doi = {10.1371/journal.pone.0345280}
}
Kostenlos starten →